New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain

New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	HOBOKEN, NJ – June 14, 2006 – A study published in this month’s issue of Angiology shows that supplementation with the pine bark extract Pycnogenol® (pic-noj-en-all) improves blood flow to the muscles which speeds recovery after physical exercise. The study of 113 participants demonstrated that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. “With the millions of athletes worldwide, this truly is a profound breakthrough and extremely significant for all individuals interested in muscle cramp and pain relief with a natural approach. These findings indicate that Pycnogenol can play an important role in sports by improving blood flow to the muscles and hastening post-exercise recovery, said Dr. Peter Rohdewald, a lead researcher of the study. Researchers at L’Aquila University in Italy and at the University of Würzburg in Germany studied the effects of Pycnogenol on venous disorders and cramping in two separate studies. The first study consisted of 66 participants who had experienced normal cramping at some point, had venous insufficiency, or were athletes who suffer from exercise-induced cramping. The first two weeks of the study was an observation period and participants did not supplement with Pycnogenol. Symptoms related to venous disorders, and the number of cramping episodes each participant experienced over the two observation weeks was recorded. Next, all the participants were given 200 mg of Pycnogenol once a day for four weeks. After the treatment phase, participants’ symptoms and cramping episodes were recorded for one week without any Pycnogenol supplementation. The researchers found a significant decrease in the number of cramps the participants experienced while supplementing with Pycnogenol. Participants who had experienced normal cramping had a 25 percent reduction in the number of cramps experienced while taking Pycnogenol. Participants with venous insufficiency experienced a 40 percent reduction in the number of cramps, and athletes with frequent cramping experienced a 13 percent reduction in the number of cramps while on Pycnogenol. The second study involved 47 participants with diabetic microangiopathy (a disorder of the smallest veins commonly associated with diabetes), or intermittent claudication (a blood vessel disease that causes the legs to easily cramp).This study also used a two-week pre-trial observation period followed by a week of supplementing with Pycnogenol (200 mg per day for one week), followed by a week of observation without Pycnogenol supplementation. Patients with diabetic microangiopathy had a 20.8 percent reduction in pain, while participants with claudication experienced a 21 percent decrease in the amount of pain experienced while supplementing with Pycnogenol. Results indicated participants who took placebo experienced no decrease in pain. Cramps are a common problem for people of all ages, ranging to the extreme fit and healthy to people who suffer from health problems. Previously, magnesium was hailed as the natural approach for relieving muscle cramps, however studies continue to show magnesium to be inefficient for reducing muscle cramps. “Pycnogenol improves the blood supply to muscle tissue creating a relief effect on muscle cramping and pain. Poor circulation in the muscle is known to cause cramps and Pycnogenol improved the cramping in patients due to a stimulation of blood flow to their muscle tissue. Nitric oxide (NO) a blood gas, is well known to enhance blood flow and Pycnogenol may be influencing the activity of NO,” said Rohdewald. “The insufficient production of NO is the common denominator responsible for impaired blood flow in vascular disease.” Strenuous exercise is known to involve muscle damage which may be followed by symptoms of inflammation. In separate studies published this year and in 2004 and 2005, Pycnogenol demonstrated its anti-inflammatory effects in clinical trials for asthma, dysmenorrhea and osteoarthritis. Pycnogenol is a natural plant extract originating from the bark of the Maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and organic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 35 years and has more than 220 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol is available in more than 400 dietary supplements, multi-vitamins and health products worldwide. For more information or a copy of this study, visit www.pycnogenol.com. ### Natural Health Science Inc., (NHS) based in Hoboken, New Jersey, is the North American distributor for Pycnogenol® (pic-noj-en-all) brand French Maritime Pine Bark Extract on behalf of Horphag Research. Pycnogenol® is a registered trademark of Horphag Research Ltd., Guernsey, and its applications are protected by U.S. patents #5,720,956 / #6,372,266 and other international patents. NHS has the exclusive rights to market and sell Pycnogenol® and benefits from more than 35 years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement. For more information about Pycnogenol® visit our web site at www.pycnogenol.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software